Arteriovenous Malformation Market Research Report - Forecast till 2027

Arteriovenous Malformation Market research report: by type (true arteriovenous malformation), diagnosis (physical examination, brain scans) treatment (endovascular embolization, neurosurgery), end user (hospitals & clinics) - Forecast till 2027

ID: MRFR/LS/3656-HCR | | Region: Global | 100 pages

Arteriovenous Malformation Market Overview:


The arteriovenous Malformation Market analysis shows that the market will attain a good business fortune during the ongoing forecast period of 2021-2028. The market is likely to expand at a CAGR of 6.70% amid the market’s operations in the arteriovenous Malformation Market scenario.


Arteriovenous malformations (AVMs) can be understood as an abnormal tangle of a blood vessel that connects the arteries and veins. This connection disrupts the normal blood flow and oxygen circulation within the human body. When AVMs occur in any part of the human body, the surrounding tissues may not be able to get enough oxygen, and hence, the affected vein and arteries get weakened and ruptured. If AVMs are tangled are in the brain and ruptured, it may lead to bleeding in the brain which leads to the major connection of hemorrhage, strokes, or brain damage. AVMs can occur anywhere within the human body but majorly they are commonly found in the brain and spine.


COVID 19 Analysis


The COVID-19 pandemic has broken the web and market drifts and has circled new freedoms and difficulties. The pandemic is a unique worldwide general wellbeing crisis. The appearance of the pandemic has influenced pretty much every industry, and the positive and negative impacts are projected to affect the business development during the ongoing forecast period that will end in 2028. The exploration expert's continuous examination intensifies their exploration system to guarantee the consideration of fundamental COVID-19 issues and possible ways ahead. The report examines that the episode of the pandemic has constrained individuals to achieve an adjustment of their way of life and purchaser inclinations. The pandemic has additionally constrained the worldwide legislatures and public area to make significant strides like lockdown and severe measures that will affect the market and the interest that may bring about misfortunes during the estimated time frame that will end in 2028.


The public authority and arteriovenous Malformation Market players are understanding the need to get back to business as usual to keep the market working with the rising rivalry in the worldwide market premises. The arteriovenous malformation market patterns are relied upon to ascend with the improved innovative work drives that are winning in the worldwide market premises during the term of the ongoing forecast period of 2021-2028.


Market Dynamics


Drivers


There has been an increasing prevalence of neurological/brain disorders like arteriovenous malformation amongst others like epilepsy. There is a rising need for better treatment for such rare diseases. Hence, there is an increasing investment of biotechnology and pharmaceutical industries in research and development, and the availability of funds is likely to drive the growth of the arteriovenous Malformation Market during the forecast period that will be ending in 2028. Moreover, there has been increasing government support for research and development sectors that are supporting changing lifestyles, and rapid development in technology. These factors are expected to fuel the arteriovenous Malformation Market growth during the forecast period that will end in 2028.


Restraints


However, the arteriovenous Malformation Market size is witnessing the birth of certain factors that might hamper the market from growing during the forecast period of 2021-2028. There has been a higher cost associated with the treatment procedure and hence, this is a major fact that might be responsible for slowing the market growth during the forecast period of 2021-2028.


Technology Analysis


However, the arteriovenous Malformation Market is witnessing an increase in the company initiatives to provide better treatment and rising investment by biotechnology and pharmaceutical industries in the research and development activities in the global market premises. This is driving the global arteriovenous Malformation Market share from 2021 through 2028. Moreover, the technological advancements in the treatment and diagnosis along with the favorable reimbursement policies also boost up the market growth, as forecasted by the industry experts and business chiefs for the ongoing forecast period that is likely to be ending in 2028.


Study Objectives



  • The worldwide arteriovenous malformation market report is concentrated to have a profound investigation of the worldwide market works previously, then after the fact the novel Covid had hit the global market scale. The report plans to have a thought regarding the market elements like the chances and drivers that will help the market during the estimated time frame that will end in 2028. The arteriovenous Malformation Market report additionally means fostering comprehension of the limitations that may challenge the market from developing according to the forecasts.

  • The market report additionally examines the premise of the worldwide market division through which the market is working in a progression of worldwide areas for meeting the rising necessities of the interest group that is spread in the noticeable spots for the market and consequently, assist the market with developing per the potential income that has been estimated for the period that will end in 2028.

  • The arteriovenous Malformation Market report expects to have a thought regarding the rising business sector rivalry that is a consequence of the patterns and advancements that have been in the method of rising and extension in the worldwide business during the ongoing forecast period and further, help the financial backers settle on better choices.


Segment Overview


The AVM Market is witnessing the market scenarios and trends that support a substantial rise in the demand for the market expansion and availability in various global locations during the forecast period. The market segmentation is proof that the market is likely to function well and cater to the rising needs of the target audience. The segments are mentioned as follows:


Based on the market types


It is segmented based on the type and includes true arteriovenous malformation, occult or cryptic AVM or cavernous malformations, venous malformation, hemangioma, and dural fistula.


Based on the diagnosis


The AVM Market has been segmented based on diagnosis and includes a physical examination, blood test, brain scans, and others. Brain scan segment has further been segmented into computerized tomography (CT) scan, Magnetic Resonance Imaging (MRI), magnetic resonance angiography (MRA), and electroencephalography (EEG).


Based on the treatment


The arteriovenous malformation market is segmented based on the treatment and includes endovascular embolization, neurosurgery, and others.


Based on the market end-user


The market is segmented into hospitals and clinics, research laboratories amongst others.


Regional Analysis


The arteriovenous malformation market has been segmented based on geographical regions and is functional in five major regions across the globe. The North American region is likely to dominate the global arteriovenous malformation market owing to the huge presence and functioning of the patient population alongside the rising ability for high health care spending. The increasing government support for research & development is also helping the global market.    


Europe holds the second-largest share in the global market as per the predictions for the forecast period. The increased focus of various public and government agencies on treating various brain disorders or brain injuries inclusive of epilepsy and depression will have a positive impact on the growth of the European market amid the forecast period. The growing degree of public awareness will boost the adoption of these devices in the European market amid the forecast period.


Competitive Landscape


The rising market competition is a result of the following market players:



  • Toshiba Medical Systems Corporation (Japan)

  • Fujifilm Holdings (Japan)

  • Carestream Health (U.S.)

  • Electrical Geodesics Inc. (U.S.)

  • Nihon Kohden Corporation (Japan)


Recent Developments



  • The Asian Pacific region and country-wise market players are projected to emerge as the fastest-growing arteriovenous malformation market across the globe amid the rising market competition. Japan holds a major market share for being one of the most prominent places as the regional market due to the increasing availability of technology and huge healthcare spending owing to the rise in the disposable income of people in the APAC region.

  • The Middle East and Africa were holding the least share of the global market due to the limited availability of medical facilities during the historic forecast period that had ended in 2019. The countries, as a part of the region like UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East & African market for the ongoing forecast period of 2021-2028.

  • The African region is expected to witness a moderate degree of growth owing to the rising developments that have been undertaken by the prominent industry players which is a result of the rising funds and investments.


Report Overview


The arteriovenous malformation market report helps in understanding the market patterns that are likely to gain momentum in the ongoing forecast period of 2021-2028. The market report helps the potential investors and buyers understand the scenarios so that they can invest accordingly. The market report also discusses the impact of the pandemic outbreak on the market during the period that ends in 2028.


 



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   6.10% (2017-2027)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Types, Diagnosis, Treatment, and End user
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Toshiba Medical Systems Corporation (Japan), Carestream Health (U.S.), Nihon Kohden Corporation (Japan), Electrical Geodesics Inc. (U.S.), Fujifilm Holdings (Japan), GE Healthcare (U.S.), Siemens Healthcare(U.S.), Philips Healthcare (U.S.), Shimadzu Corporation (Japan), Masimo Corporation (U.S.), Hologic (U.S.), Esaote (Italy), and others
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • Increasing prevalence of brain diseases/disorders
  • Increasing investment by biotechnology and pharmaceutical industries in R&D
  • Rising need for the better treatment methods


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :


    Arteriovenous malformation market is expected to exhibit a CAGR of 6.1% from 2017 to 2027.

    Rising prevalence of strokes and neurological disorders and investments by major biotechnology companies are major drivers of the global arteriovenous malformation market.

    The Americas can dominate the global arteriovenous malformation market due to a large healthcare expenditure and a large patient pool of brain disorders.

    The Middle East & Africa (MEA) can showcase the lowest growth rate in the global arteriovenous malformation market due to lack of funds and limited number of facilities.

    Toshiba Medical Systems Corporation, Fujifilm Holdings, Philips Healthcare, Carestream Health, Esaote, Shimadzu Corporation, Hologic, Masimo Corporation, GE Healthcare, Electrical Geodesics Inc., Siemens Healthcare, and Nihon Kohden Corporation are notable players of the global arteriovenous malformation market.

    Table of Content

    1. Report Prologue

    2. Market Introduction

    2.1 Definition

    2.2 Scope of the Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations

    3. Research Methodology

    3.1 Introduction

    3.2 Primary Research

    3.3 Secondary research

    3.4 Market Size Estimation

    4. Market Dynamics

    4.1 Drivers

    4.2 Restrains

    4.3 Opportunities

    4.4 Challenges

    4.5 Macroeconomic Indicators

    4.6 Technology Trends & Assessment

    5. Market Factor Analysis

    5.1 Porters Five Forces Analysis

    5.1.1 Bargaining Power of Suppliers

    5.1.2 Bargaining Power of Buyers

    5.1.3 Threat of New Entrants

    5.1.4 Threat of Substitutes

    5.1.5 Intensity of Rivalry

    5.2 Value Chain Analysis

    5.3 Investment Feasibility Analysis

    5.4 Pricing Analysis

    6. Global Arteriovenous Malformation Market, by Type

    6.1 Introduction

    6.2 True Arteriovenous Malformation

    6.2.1 Market Estimates & Forecast, 2020-2027

    6.3 Occult or Cryptic AVM or Cavernous Malformations

    6.3.1 Market Estimates & Forecast, 2020-2027

    7. Global Arteriovenous Malformation Market, by Diagnosis

    7.1 Introduction

    7.2 Physical examination

    7.2.1 Market Estimates & Forecast, 2020-2027

    7.3 Brain Scans

    7.3.1 Market Estimates & Forecast, 2020-2027

    7.4 Others

    7.4.1 Market Estimates & Forecast, 2020-2027

    8. Global Arteriovenous Malformation Market, by Treatment

    8.1 Introduction

    8.2 Endovascular Embolization

    8.2.1 Market Estimates & Forecast, 2020-2027

    8.3 Neurosurgery

    8.3.1 Market Estimates & Forecast, 2020-2027

    9. Global Arteriovenous Malformation Market, by End User

    9.1 Introduction

    9.2 Hospitals & clinics

    9.2.1 Market Estimates & Forecast, 2020-2027

    9.3 Research laboratories

    9.3.1 Market Estimates & Forecast, 2020-2027

    9.4 Others

    9.4.1 Market Estimates & Forecast, 2020-2027

    10. Global Arteriovenous Malformation Market, by Region

    10.1 Introduction

    10.2 Americas

    10.2.1 North America

    10.2.1.1 US

    10.2.1.1 Canada

    10.2.2 South America

    10.3 Europe

    10.3.1 Western Europe

    10.3.1.1 Germany

    10.3.1.2 France

    10.3.1.3 U.K

    10.3.1.4 Italy

    10.3.1.5 Spain

    10.3.1.6 Rest of Western Europe

    10.3.2 Eastern Europe

    10.4 Asia Pacific

    10.4.1 Japan

    10.4.2 China

    10.4.3 India

    10.4.4 Australia

    10.4.5 Republic of Korea

    10.4.6 Rest of Asia Pacific

    10.5 The Middle East & Africa

    10.5.1 United Arab Emirates

    10.5.2 Saudi Arabia

    10.5.3 Oman

    10.5.4 Kuwait

    10.5.5 Qatar

    10.5.6 Rest of the Middle East & Africa

    11 Company Landscape

    11.1 Introduction

    11.2 Market Share Analysis

    11.3 Key Development & Strategies

    11.3.1 Key Developments

    12. Company Profiles

    12.1 Fujifilm Holdings

    12.1.1 Company Overview

    12.1.2 Product Overview

    12.1.3 Financials

    12.1.4 SWOT Analysis

    12.2 GE Healthcare

    12.2.1 Company Overview

    12.2.2 Product Overview

    12.2.3 Financial Overview

    12.2.4 Key Developments

    12.2.5 SWOT Analysis

    12.3 Siemens Healthcare

    12.3.1 Company Overview

    12.3.2 Product Overview

    12.3.3 Financial Overview

    12.3.4 Key Development

    12.3.5 SWOT Analysis

    12.4 Philips Healthcare

    12.4.1 Company Overview

    12.4.2 Product/Business Segment Overview

    12.4.3 Financial Overview

    12.4.4 Key Development

    12.4.5 SWOT Analysis

    12.5 Shimadzu Corporation

    12.5.1 Company Overview

    12.5.2 Product Overview

    12.5.3 Financial overview

    12.5.4 Key Developments

    12.6 Toshiba Medical Systems Corporation

    12.6.1 Company Overview

    12.6.2 Product Overview

    12.6.3 Financial Overview

    12.6.4 Key Developments

    12.7 Carestream Health

    12.7.1 Overview

    12.7.2 Product Overview

    12.7.3 Financials

    12.7.4 Key Developments

    12.7.5 SWOT Analysis

    12.8 Others

    13 MRFR Conclusion

    13.1 Key Findings

    13.1.1 From CEO’s View Point

    13.1.2 Unmet Needs of the Market

    13.2 Key Companies to Watch

    13.3 Prediction of Pharmaceutical Industry

    14 Appendix

    LIST OF TABLES

    Table 1 Arteriovenous Malformation Industry Synopsis, 2020-2027

    Table 2 Global Arteriovenous Malformation Market Estimates and Forecast, 2020-2027, (USD Million)

    Table 3 Global Arteriovenous Malformation Market by Region, 2020-2027, (USD Million)

    Table 4 Global Arteriovenous Malformation Market by Types, 2020-2027, (USD Million)

    Table 5 Global Arteriovenous Malformation Market by Diagnosis, 2020-2027, (USD Million)

    Table 6 Global Arteriovenous Malformation Market by Treatment, 2020-2027, (USD Million)

    Table 7 Global Arteriovenous Malformation Market by End Users, 2020-2027, (USD Million)

    Table 8 North America Arteriovenous Malformation Market by Types, 2020-2027, (USD Million)

    Table 9 North America Arteriovenous Malformation Market by Diagnosis, 2020-2027, (USD Million)

    Table 10 North America Arteriovenous Malformation Market by Treatment, 2020-2027, (USD Million)

    Table 11 North America Arteriovenous Malformation Market by End Users, 2020-2027, (USD Million)

    Table 12 US Arteriovenous Malformation Market by Types, 2020-2027, (USD Million)

    Table 13 US Arteriovenous Malformation Market by Diagnosis, 2020-2027, (USD Million)

    Table 14 US Arteriovenous Malformation Market by Treatment, 2020-2027, (USD Million)

    Table 15 US Arteriovenous Malformation Market by End Users, 2020-2027, (USD Million)

    Table 16 Canada Arteriovenous Malformation Market by Types, 2020-2027, (USD Million)

    Table 17 Canada Arteriovenous Malformation Market by Diagnosis, 2020-2027, (USD Million)

    Table 18 Canada Arteriovenous Malformation Market by Treatment, 2020-2027, (USD Million)

    Table 19 Canada Arteriovenous Malformation Market by End Users, 2020-2027, (USD Million)

    Table 20 South America Arteriovenous Malformation Market by Types, 2020-2027, (USD Million)

    Table 21 South America Arteriovenous Malformation Market by Diagnosis, 2020-2027, (USD Million)

    Table 22 South America Arteriovenous Malformation Market by Treatment, 2020-2027, (USD Million)

    Table 23 South America Arteriovenous Malformation Market by End Users, 2020-2027, (USD Million)

    Table 24 Europe Arteriovenous Malformation Market by Types, 2020-2027, (USD Million)

    Table 25 Europe Arteriovenous Malformation Market by Diagnosis, 2020-2027, (USD Million)

    Table 26 Europe Arteriovenous Malformation Market by Treatment, 2020-2027, (USD Million)

    Table 27 Europe Arteriovenous Malformation Market by End Users, 2020-2027, (USD Million)

    Table 28 Western Europe Arteriovenous Malformation Market by Types, 2020-2027, (USD Million)

    Table 29 Western Europe Arteriovenous Malformation Market by Diagnosis, 2020-2027, (USD Million)

    Table 30 Western Europe Arteriovenous Malformation Market by Treatment, 2020-2027, (USD Million)

    Table 31 Western Europe Arteriovenous Malformation Market by End Users, 2020-2027, (USD Million)

    Table 32 Eastern Europe Arteriovenous Malformation Market by Types, 2020-2027, (USD Million)

    Table 33 Eastern Europe Arteriovenous Malformation Market by Diagnosis, 2020-2027, (USD Million)

    Table 34 Eastern Europe Arteriovenous Malformation Market by Treatment, 2020-2027, (USD Million)

    Table 35 Eastern Europe Arteriovenous Malformation Market by End Users, 2020-2027, (USD Million)

    Table 36 Asia Pacific Arteriovenous Malformation Market by Types, 2020-2027, (USD Million)

    Table 37 Asia Pacific Arteriovenous Malformation Market by Diagnosis, 2020-2027, (USD Million)

    Table 38 Asia Pacific Arteriovenous Malformation Market by Treatment, 2020-2027, (USD Million)

    Table 39 Asia Pacific Arteriovenous Malformation Market by End Users, 2020-2027, (USD Million)

    Table 40 Middle East & Africa Arteriovenous Malformation Market by Types, 2020-2027, (USD Million)

    Table 41 Middle East & Africa Arteriovenous Malformation Market by Diagnosis, 2020-2027, (USD Million)

    Table 42 Middle East & Africa Arteriovenous Malformation Market by Treatment, 2020-2027, (USD Million)

    Table 43 Middle East & Africa Arteriovenous Malformation Market by End Users, 2020-2027, (USD Million)

    LIST OF FIGURES

    Figure 1 Research Process

    Figure 2 Segmentation for Global Arteriovenous Malformation Market

    Figure 3 Segmentation Market Dynamics for Arteriovenous Malformation Market

    Figure 4 Global Arteriovenous Malformation Market Share, by Diagnosis 2020

    Figure 5 Global Arteriovenous Malformation Market Share, by Treatment 2020

    Figure 6 Global Arteriovenous Malformation Market Share, by End Users, 2020

    Figure 7 Global Arteriovenous Malformation Market Share, by Region, 2020

    Figure 8 North America Arteriovenous Malformation Market Share, by Country, 2020

    Figure 9 Europe Arteriovenous Malformation Market Share, by Country, 2020

    Figure 10 Asia Pacific Arteriovenous Malformation Market Share, by Country, 2020

    Figure 11 Middle East & Africa Arteriovenous Malformation Market Share, by Country, 2020

    Figure 12 Global Arteriovenous Malformation Market: Company Share Analysis, 2020 (%)

    Figure 13 Fujifilm Holdings: Key Financials

    Figure 14 Fujifilm Holdings: Segmental Revenue

    Figure 15 Fujifilm Holdings: Geographical Revenue

    Figure 16 GE Healthcare: Key Financials

    Figure 17 GE Healthcare: Segmental Revenue

    Figure 18 GE Healthcare: Geographical Revenue

    Figure 19 Siemens Healthcare: Key Financials

    Figure 20 Siemens Healthcare: Segmental Revenue

    Figure 21 Siemens Healthcare: Geographical Revenue

    Figure 22 Philips Healthcare: Key Financials

    Figure 23 Philips Healthcare: Segmental Revenue

    Figure 24 Philips Healthcare: Geographical Revenue

    Figure 25 Shimadzu Corporation.: Key Financials

    Figure 26 Shimadzu Corporation: Segmental Revenue

    Figure 27 Shimadzu Corporation: Geographical Revenue

    Figure 28 Toshiba Medical Systems Corporation: Key Financials

    Figure 29 Toshiba Medical Systems Corporation: Segmental Revenue

    Figure 30 Toshiba Medical Systems Corporation: Geographical Revenue

    Figure 31 Carestream Health.: Key Financials

    Figure 32 Carestream Health: Segmental Revenue

    Figure 33 Carestream Health: Geographical Revenue